| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.43B | 27.89B | 26.91B | 23.90B | 19.45B | 15.56B |
| Gross Profit | 4.20B | 4.28B | 4.32B | 3.75B | 2.87B | 2.60B |
| EBITDA | 2.88B | 3.14B | 3.30B | 2.52B | 2.06B | 1.52B |
| Net Income | 1.32B | 1.26B | 949.00M | 612.00M | 245.00M | 158.00M |
Balance Sheet | ||||||
| Total Assets | 22.17B | 22.12B | 27.95B | 27.56B | 21.32B | 17.32B |
| Cash, Cash Equivalents and Short-Term Investments | 3.75B | 3.30B | 5.19B | 5.50B | 4.08B | 2.89B |
| Total Debt | 4.57B | 4.49B | 8.12B | 7.84B | 5.27B | 4.29B |
| Total Liabilities | 11.67B | 11.49B | 17.02B | 18.04B | 13.23B | 10.17B |
| Stockholders Equity | 10.50B | 10.62B | 9.25B | 7.93B | 7.06B | 6.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -582.00M | -48.00M | -1.46B | 606.00M | -971.00M |
| Operating Cash Flow | 0.00 | 2.49B | 2.69B | 2.67B | 2.43B | 1.03B |
| Investing Cash Flow | 0.00 | -2.64B | -2.69B | -3.87B | -1.32B | -1.68B |
| Financing Cash Flow | 0.00 | 148.00M | -622.00M | 2.48B | -8.00M | 496.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
70 Outperform | ¥56.34B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
68 Neutral | ¥6.74B | 2.83 | ― | 6.68% | 1.95% | ― | |
64 Neutral | ¥4.76B | 3.96 | ― | 1.95% | -11.25% | 82.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥6.44B | 3.20 | ― | 3.44% | -7.72% | -311.30% | |
54 Neutral | ¥5.57B | 8.75 | ― | 2.46% | -9.28% | -219.81% |